IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101)
Clinical trial NCT00785122 · COMPLETED
Trial details
- NCT number
- NCT00785122
- Sponsor
- Immatics Biotechnologies GmbH
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2011-01-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.